Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades
Elias Jabbour, Nicholas J. Short, Nitin Jain, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 60

Showing 26-50 of 60 citing articles:

Blinatumomab and Inotuzumab Ozogamicin Sequential Use for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: A Real-Life Campus All Study
Nicola Fracchiolla, Mariarita Sciumè, Cristina Papayannidis, et al.
Cancers (2023) Vol. 15, Iss. 18, pp. 4623-4623
Open Access | Times Cited: 9
Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22 + Philadelphia Chromosome–Negative B-Cell Precursor Acute Lymphoblastic Leukemia
Patrice Chevallier, Thibaut Leguay, Marc Delord, et al.
Journal of Clinical Oncology (2024)
Closed Access | Times Cited: 3
Efficacy of blinatumomab as maintenance therapy for B-lineage acute lymphoblastic leukemia/lymphoma following allogeneic hematopoietic cell transplantation
Jiayu Huang, Bingyang Shi, Shiyou Yu, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
SOHO State of the Art Updates and Next Questions | Approach to BCR::ABL1-Like Acute Lymphoblastic Leukemia
Ilaria Iacobucci, Cristina Papayannidis
Clinical Lymphoma Myeloma & Leukemia (2024)
Closed Access | Times Cited: 2
The combination of a tyrosine kinase inhibitor and blinatumomab in patients with Philadelphia chromosome–positive acute lymphoblastic leukemia or Philadelphia chromosome‐like acute lymphoblastic leukemia
Xiaoxia Wu, Shenqi Lu, Xinhui Zhang, et al.
Cancer Medicine (2024) Vol. 13, Iss. 17
Open Access | Times Cited: 2
Approaches for bridging therapy prior to chimeric antigen receptor T cells for relapsed/refractory acute lymphoblastic B-lineage leukaemia in children and young adults
Tobias Feuchtinger, Peter Bader, Marion Subklewe, et al.
Haematologica (2024)
Open Access | Times Cited: 1
Allogeneic stem cell transplantation is still a highly curative therapy in adults with philadelphia chromosome–positive acute lymphoblastic leukaemia
Lijuan Hu, Zongru Li, Sen Yang, et al.
Annals of Hematology (2024) Vol. 103, Iss. 9, pp. 3745-3754
Closed Access | Times Cited: 1
Is intensive chemotherapy and allogeneic stem cell transplantation mandatory for curing Philadelphia chromosome-positive acute lymphoblastic leukemia in young patients in the era of multitarget agents?
Sang Kyun Sohn, Jung Min Lee, Young‐Eun Jang, et al.
Expert Review of Hematology (2024) Vol. 17, Iss. 7, pp. 353-359
Closed Access | Times Cited: 1
Liver elastography for risk-assessment of liver toxicity and risk factors for Sinusoidal obstruction syndrome in patients with acute lymphoblastic leukemia receiving inotuzumab ozogamicin
Jayastu Senapati, Elias Jabbour, Nicholas J. Short, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Recent Developments and Challenges in the Treatment of Acute Leukemia and Myelodysplastic Syndromes: A Systematic Review
Nawal Rafiq, Muhammad H Khan, Mashaal Sahibzada, et al.
Cureus (2024)
Open Access | Times Cited: 1
CAR-T-Cell Therapy Based on Immune Checkpoint Modulation in the Treatment of Hematologic Malignancies
Manqi Su, Zhanna Zhang, Panruo Jiang, et al.
Cell Transplantation (2024) Vol. 33
Open Access | Times Cited: 1
Frontline Ph-negative B-cell precursor acute lymphoblastic leukemia treatment and the emerging role of blinatumomab
Elias Jabbour, Hagop M. Kantarjian, Nicola Goekbuget, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Targeting miR-126 in Ph+ acute lymphoblastic leukemia
Jun-Jing Qiao, Dandan Zhao, Le Xuan Truong Nguyen, et al.
Leukemia (2023) Vol. 37, Iss. 7, pp. 1540-1544
Open Access | Times Cited: 2
Nomogram predictive models for adult patients with acute lymphoblastic leukaemia based on real-world treatment outcomes
Yi Chen, Yanxin Chen, Zhengjun Wu, et al.
Annals of Hematology (2024) Vol. 103, Iss. 7, pp. 2393-2404
Closed Access
Evaluation of next-generation sequencing for measurable residual disease monitoring in three major fusion transcript subtypes of B-precursor acute lymphoblastic leukaemia
Ying‐Jung Huang, Shih‐Hsiang Chen, Hsi‐Che Liu, et al.
Pathology (2024) Vol. 56, Iss. 5, pp. 681-687
Closed Access
Minnelide exhibits antileukemic activity by targeting the Ars2/miR-190a-3p axis
Yuan Liang, Xiuxing Jiang, Guanfei Jia, et al.
Phytomedicine (2024) Vol. 130, pp. 155724-155724
Open Access
BRG1 promotes progression of B-cell acute lymphoblastic leukemia by disrupting PPP2R1A transcription
Qian Kang, Dan Ma, Peng Zhao, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 8
Open Access
Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia can be Treated with Chemotherapy-Free Regimens without Transplant
Fadi G. Haddad, Hagop M. Kantarjian, Jayastu Senapati, et al.
Clinical Lymphoma Myeloma & Leukemia (2024) Vol. 24, pp. S79-S82
Closed Access
Exploitation of the fibrinolytic system by B-cell acute lymphoblastic leukemia and its therapeutic targeting
Valentina R. Minciacchi, Jimena Bravo, Christina Karantanou, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access
CD58 expression does not impact response to inotuzumab ozogamicin in patients with B‐cell acute lymphoblastic leukemia
Rafael Madero‐Marroquin, Ryan W. Hunter, Caner Saygin, et al.
eJHaem (2024) Vol. 6, Iss. 1
Open Access
Bilateral optic nerve infiltration and leukemic retinopathy as initial signs of leukemia relapse with central nervous system involvement in an adult: A case report
Yisai Wang, Ling Zhu, Hongtao Wang, et al.
Research Square (Research Square) (2024)
Open Access
SOHO State of the Art Updates and Next Questions | Novel Agents and the Diminishing Role of Allogeneic Stem Cell Transplant in B-Acute Lymphoblastic Leukemia
Wei‐Ying Jen, Elias Jabbour, Hagop M. Kantarjian, et al.
Clinical Lymphoma Myeloma & Leukemia (2024) Vol. 24, Iss. 9, pp. 565-572
Closed Access
A retrospective study of ovarian tissue cryopreservation in female patients with hematological diseases for fertility preservation
Yiling Wang, Qing-Jie Zhai, Zhaohua Wang, et al.
Archives of Gynecology and Obstetrics (2024) Vol. 309, Iss. 6, pp. 2863-2880
Closed Access
[Safety and efficacy of donor-derived chimeric antigen receptor T-cell therapy in patients with relapsed B-cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation].
Yue Zhuo, Sanfang Tu, Xuan Zhou, et al.
PubMed (2024) Vol. 45, Iss. 1, pp. 74-81
Closed Access
Prevalence and Treatment Outcomes of Childhood Acute Lymphoblastic Leukemia in Kosovo
Flaka Pasha, Dunja Urbančič, Rufadie Maxhuni, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 1988-1988
Open Access

Scroll to top